tiprankstipranks
Trending News
More News >
AFLAC (AFL)
NYSE:AFL
US Market
Advertisement

AFLAC (AFL) Earnings Dates, Call Summary & Reports

Compare
2,042 Followers

Earnings Data

Report Date
Feb 04, 2026
After Close (Confirmed)
Period Ending
2025 (Q4)
Consensus EPS Forecast
1.7
Last Year’s EPS
1.56
Same Quarter Last Year
Based on 10 Analysts Ratings

Earnings Call Summary

Q3 2025
Earnings Call Date:Nov 04, 2025|
% Change Since:
|
Earnings Call Sentiment|Positive
The earnings call presented a largely positive outlook with strong financial performance in both the U.S. and Japan segments, robust capital deployment, and significant sales growth in Japan's cancer insurance sector. However, challenges remain in the U.S., particularly with the shift away from individual products and expense management issues.
Company Guidance
During the Aflac Inc. Third Quarter 2025 Earnings Call, several key metrics were discussed, highlighting the company's performance. Aflac reported net earnings per diluted share of $3.08 and adjusted earnings per diluted share of $2.49, indicating strong financial results. Aflac Japan experienced an 11.8% year-over-year sales increase, with cancer insurance sales surging by 42%, largely driven by the Miraito product launched in March. In the U.S., new sales for the quarter amounted to $390 million, reflecting a 2.8% year-over-year increase, while maintaining strong premium persistency at 79% and net earned premiums rising by 2.5%. Aflac's capital management was underscored by a record $1 billion in capital deployed to repurchase 9.3 million shares and $309 million paid in dividends, totaling $1.3 billion returned to shareholders. The company also maintained a strong capital position with leverage at 22% and unencumbered holding company liquidity of $4.5 billion. Financial guidance for 2025 included expectations for Japan's benefit ratio to be between 58% and 60% and the U.S. benefit ratio at the lower end of the 48% to 52% range, with strategic initiatives supporting these goals.
Strong Earnings Per Share
Aflac reported net earnings per diluted share of $3.08 and adjusted earnings per diluted share of $2.49 for Q3 2025, a 15.3% increase year-over-year.
Significant Growth in Japan
Aflac Japan experienced an 11.8% year-over-year sales increase, with a 42% increase in cancer insurance sales driven by the Miraito product.
Capital Deployment
Aflac deployed a record $1 billion in capital to repurchase 9.3 million shares and paid dividends of $309 million, returning $1.3 billion to shareholders in Q3 2025.
Strong Performance in U.S. Buy-to-Build Initiatives
The U.S. segment saw $390 million in new sales with a 2.8% year-over-year increase and maintained a strong premium persistency of 79%.
Milestone Achievements
2025 marks Aflac's 70th anniversary, 43 consecutive years of dividend increases, and significant anniversaries for the Aflac Cancer and Blood Disorders Center and the Aflac Duck.

AFLAC (AFL) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

AFL Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
Feb 04, 2026
2025 (Q4)
1.70 / -
1.56
Nov 04, 2025
2025 (Q3)
1.77 / 2.49
2.1615.28% (+0.33)
Aug 05, 2025
2025 (Q2)
1.70 / 1.78
1.83-2.73% (-0.05)
Apr 30, 2025
2025 (Q1)
1.67 / 1.66
1.660.00% (0.00)
Feb 05, 2025
2024 (Q4)
1.62 / 1.56
1.2821.88% (+0.28)
Oct 30, 2024
2024 (Q3)
1.69 / 2.16
1.8417.39% (+0.32)
Jul 31, 2024
2024 (Q2)
1.60 / 1.83
1.5815.82% (+0.25)
May 01, 2024
2024 (Q1)
1.58 / 1.66
1.557.10% (+0.11)
Jan 31, 2024
2023 (Q4)
1.45 / 1.28
1.4-8.57% (-0.12)
Nov 01, 2023
2023 (Q3)
1.49 / 1.84
1.2349.59% (+0.61)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

AFL Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Nov 04, 2025
$108.81$111.24+2.23%
Aug 05, 2025
$98.38$101.75+3.43%
Apr 30, 2025
$107.50$102.39-4.75%
Feb 05, 2025
$105.53$101.39-3.92%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does AFLAC (AFL) report earnings?
AFLAC (AFL) is schdueled to report earning on Feb 04, 2026, After Close (Confirmed).
    What is AFLAC (AFL) earnings time?
    AFLAC (AFL) earnings time is at Feb 04, 2026, After Close (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is AFL EPS forecast?
          AFL EPS forecast for the fiscal quarter 2025 (Q4) is 1.7.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis